.png)
Agenzia Italiana del Farmaco
Updated lists of allergens for specific immunotherapy and diagnosis published following the end of the transitional phase initiated with AIFA Decision DG 2130/2017 - Updated lists of allergens for specific immunotherapy and diagnosis published following the end of the transitional phase initiated with AIFA Decision DG 2130/2017
Updated lists of allergens for specific immunotherapy and diagnosis published following the end of the transitional phase initiated with AIFA Decision DG 2130/2017
Following a request from the companies concerned and, where relevant, after an evaluation by the Agency, the lists already published following the end of the transitional phase initiated with AIFA Decision DG 2130/2017 were updated on 10 December 2021. Specifically, the update concerns the lists of allergens for specific immunotherapy and diagnosis for which companies may continue the procedure for obtaining a marketing authorisation (Annex 1), for which the Agency has issued a refusal to continue the procedure (Annex 2) and for which companies have waived the procedure for obtaining a marketing authorisation (Annex 3).
Published on: 13 December 2021
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR